GlucoTrack, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 7.1 million compared to USD 4.44 million a year ago. Basic loss per share from continuing operations was USD 0.38 compared to USD 0.29 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5428 USD | +19.22% | -38.96% | +110.33% |
Apr. 22 | GlucoTrack, Inc. announced that it has received $0.5 million in funding | CI |
Apr. 16 | Glucotrack Expanding Glucose Monitoring Technology to Epidural Space | MT |
1st Jan change | Capi. | |
---|---|---|
+110.33% | 12.18M | |
+2.61% | 42.75B | |
+47.70% | 41.61B | |
+12.01% | 41.34B | |
-8.83% | 26.59B | |
+7.22% | 25.49B | |
-22.43% | 18.12B | |
+30.61% | 12.24B | |
-1.85% | 11.76B | |
+9.00% | 11B |
- Stock Market
- Equities
- GCTK Stock
- News GlucoTrack, Inc.
- GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023